Duo Oncology
Developer of a clinical-stage biotechnology platform designed to replace traditional chemotherapy with more precise and tolerable cancer treatments. The company offers targeted, next-generation cancer...
Valuation
$0
Share Price
N/A
Total Raised
$13.1M
Last Round
N/A